NCT06642181View on ClinicalTrials.gov

Combined Guanfacine and Mindfulness Meditation as an Adjunct to Buprenorphine Maintenance in Opioid Use Disorder

PHASE1RecruitingINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

July 15, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

September 30, 2026

Conditions
MindfulnessGuanfacineOpioid Use Disorder
Interventions
DRUG

Guanfacine pharmacotherapy

It is a pharmacotherapy

BEHAVIORAL

Mindfulness Oriented Recovery Enhancement (MORE)

It is a mindfulness intervention

Trial Locations (1)

07107

RECRUITING

Rutgers School of Health Professions, Newark

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Rutgers, The State University of New Jersey

OTHER